Cargando…
The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease
Chronic liver disease (CLD) has emerged as a leading cause of human deaths. It caused 1.32 million deaths in 2017, which affected men more than women by a two-to-one ratio. There are various causes of CLD, including obesity, excessive alcohol consumption, and viral infection. Among them, non-alcohol...
Autores principales: | Winarto, Jessica, Song, Dae-Geun, Pan, Cheol-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179653/ https://www.ncbi.nlm.nih.gov/pubmed/37175909 http://dx.doi.org/10.3390/ijms24098203 |
Ejemplares similares
-
Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease
por: Chang, Eugene, et al.
Publicado: (2013) -
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
por: Hajduch, Eric, et al.
Publicado: (2021) -
Role of Leptin in Non-Alcoholic Fatty Liver Disease
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021) -
The Role of Non-Alcoholic Fatty Liver Disease in Infections
por: Krznarić, Juraj, et al.
Publicado: (2022) -
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)